Skip to main content
Top
Published in: Medical Oncology 4/2011

01-12-2011 | Original paper

Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy

Authors: Hana Kalábová, Bohuslav Melichar, Leoš Ungermann, Jiří Doležal, Lenka Krčmová, Markéta Kašparová, Jiří Plíšek, Radomír Hyšpler, Miroslav Pecka, Dagmar Solichová

Published in: Medical Oncology | Issue 4/2011

Login to get access

Abstract

An increased incidence of complications of atherosclerosis has been noted in cancer survivors. The aim of the present study was to evaluate, in patients with breast carcinoma, the effect of antracycline-based chemotherapy on carotid intima-media thickness (IMT), myocardial perfusion, assessed by single-photon emission tomography (SPECT) and laboratory parameters associated with the risk of atherosclerosis. Thirty-six patients with breast cancer were evaluated before and after anthracycline-based chemotherapy. Retinol, alpha-tocopherol, glycosylated hemoglobin and urinary neopterin were measured by high-performance liquid chromatography. Peripheral blood cell count, D-dimers, fibrinogen, antithrombin, glucose, magnesium, creatinine, uric acid, albumin, C-reactive protein, lipoprotein (a), cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, homocysteine, urinary albumin and N-acetyl-beta-d-glucosaminidase (NAG) were determined with routine methods. No significant differences were observed between patients and 16 controls. Compared to the measurement before the start of therapy, peripheral blood leukocyte and platelet count, hemoglobin, creatinine, HDL cholesterol, retinol, albumin, urinary albumin and NAG decreased, and total cholesterol, LDL cholesterol, triglycerides, neopterin and mean IMT increased significantly after the treatment. Of the 36 patients who had SPECT after treatment, perfusion defects were noted only in two cases, including the patient who had perfusion defects at baseline examination and a patient who did not have a baseline SPECT. In conclusion, a significant increase in carotid IMT, total cholesterol, LDL cholesterol, triglycerides and urinary neopterin and a decrease of peripheral blood leukocyte and platelet counts, hemoglobin, creatinine, HDL cholesterol, retinol, albumin and NAG were observed after the treatment.
Literature
1.
go back to reference Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–10.PubMed Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–10.PubMed
2.
go back to reference Ogawa A, Kanda T, Sugihara S, Masumo H, Kobayashi I. Risk factors for myocardial infarction in cancer patients. J Med. 1995;26:221–33.PubMed Ogawa A, Kanda T, Sugihara S, Masumo H, Kobayashi I. Risk factors for myocardial infarction in cancer patients. J Med. 1995;26:221–33.PubMed
3.
go back to reference Huddart RA, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol. 2003;21:1513–23.PubMedCrossRef Huddart RA, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol. 2003;21:1513–23.PubMedCrossRef
4.
go back to reference Meinardi MT, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol. 2000;18:1725–32.PubMed Meinardi MT, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol. 2000;18:1725–32.PubMed
5.
go back to reference Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J Clin Oncol. 2004;22:640–7.PubMedCrossRef Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J Clin Oncol. 2004;22:640–7.PubMedCrossRef
6.
go back to reference Nuver J, et al. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer. 2004;40:701–6.PubMedCrossRef Nuver J, et al. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer. 2004;40:701–6.PubMedCrossRef
7.
go back to reference Kopelson G, Herwig KJ. The etiologies of coronary artery disease in cancer patients. Int J Radiat Oncol Biol Phys. 1978;4:895–906.PubMed Kopelson G, Herwig KJ. The etiologies of coronary artery disease in cancer patients. Int J Radiat Oncol Biol Phys. 1978;4:895–906.PubMed
8.
go back to reference Pehrsson SK, Linnersjo A, Hammar N. Cancer risk of patients with ischaemic syndromes. J Intern Med. 2005;258:124–32.PubMedCrossRef Pehrsson SK, Linnersjo A, Hammar N. Cancer risk of patients with ischaemic syndromes. J Intern Med. 2005;258:124–32.PubMedCrossRef
9.
go back to reference Jagsi R, Grifith KA, Koelling T, Roberts R, Pierce LJ. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer. 2007;109:650–7.PubMedCrossRef Jagsi R, Grifith KA, Koelling T, Roberts R, Pierce LJ. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer. 2007;109:650–7.PubMedCrossRef
10.
go back to reference Jagsi R, Grifith KA, Koelling T, Roberts R, Pierce LJ. Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. J Clin Oncol. 2006;24:2779–85.PubMedCrossRef Jagsi R, Grifith KA, Koelling T, Roberts R, Pierce LJ. Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. J Clin Oncol. 2006;24:2779–85.PubMedCrossRef
11.
go back to reference Ridker PM. Novel risk factors and markers for coronary disease. Adv Intern Med. 2000;45:391–419.PubMed Ridker PM. Novel risk factors and markers for coronary disease. Adv Intern Med. 2000;45:391–419.PubMed
12.
go back to reference Grammer TB, Fuchs D, Boehm BO, Winkelmann BR, Maerz W. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem. 2009;55:1135–46.PubMedCrossRef Grammer TB, Fuchs D, Boehm BO, Winkelmann BR, Maerz W. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem. 2009;55:1135–46.PubMedCrossRef
13.
go back to reference Hachamovitch R, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Circulation. 1998;97:535–43.PubMed Hachamovitch R, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Circulation. 1998;97:535–43.PubMed
14.
go back to reference De Lorenzo A, Lima RSL, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002;90:827–32.PubMedCrossRef De Lorenzo A, Lima RSL, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002;90:827–32.PubMedCrossRef
15.
go back to reference Nguyen-Thanh H-T, Benzaquen BS. Screening for subclinical coronary artery disease measuring carotid intima media thickness. Am J Cardiol. 2009;104:1383–8.PubMedCrossRef Nguyen-Thanh H-T, Benzaquen BS. Screening for subclinical coronary artery disease measuring carotid intima media thickness. Am J Cardiol. 2009;104:1383–8.PubMedCrossRef
16.
go back to reference Melichar B, et al. Urinary neopterin, hemoglobin and peripheral blood cell counts in breast carcinoma patients treated with dose-dense chemotherapy. Anticancer Res. 2008;28:2389–96.PubMed Melichar B, et al. Urinary neopterin, hemoglobin and peripheral blood cell counts in breast carcinoma patients treated with dose-dense chemotherapy. Anticancer Res. 2008;28:2389–96.PubMed
17.
go back to reference Melichar B, et al. Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma. Anticancer Res. 2009;29:3337–46.PubMed Melichar B, et al. Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma. Anticancer Res. 2009;29:3337–46.PubMed
18.
go back to reference Melichar B, et al. Serum homocysteine, cholesterol, retinol, α-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin. Anticancer Res. 2009;29:4813–20.PubMed Melichar B, et al. Serum homocysteine, cholesterol, retinol, α-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin. Anticancer Res. 2009;29:4813–20.PubMed
19.
go back to reference Melichar B, et al. Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients. Scand J Clin Lab Inv. 1995;55:149–52.CrossRef Melichar B, et al. Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients. Scand J Clin Lab Inv. 1995;55:149–52.CrossRef
20.
go back to reference Roman MJ, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vasular Medicine and Biology. Vasc Med. 2006;11:201–11.PubMedCrossRef Roman MJ, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vasular Medicine and Biology. Vasc Med. 2006;11:201–11.PubMedCrossRef
21.
go back to reference Morales M, et al. Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer. Breast Cancer Res Treat. 1996;40:265–70.PubMedCrossRef Morales M, et al. Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer. Breast Cancer Res Treat. 1996;40:265–70.PubMedCrossRef
22.
go back to reference Tivesten A, et al. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol. 2006;9:4433–7.CrossRef Tivesten A, et al. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol. 2006;9:4433–7.CrossRef
23.
go back to reference Dorresteijn LDA, et al. Increased carotid wall thickening after radiotherapy in the neck. Eur J Cancer. 2005;41:1026–30.PubMedCrossRef Dorresteijn LDA, et al. Increased carotid wall thickening after radiotherapy in the neck. Eur J Cancer. 2005;41:1026–30.PubMedCrossRef
24.
go back to reference Simon T, et al. Influence of tamoxifen on carotid intima-media thickness in postmenopausal women. Circulation. 2002;106:2925–9.PubMedCrossRef Simon T, et al. Influence of tamoxifen on carotid intima-media thickness in postmenopausal women. Circulation. 2002;106:2925–9.PubMedCrossRef
25.
go back to reference Stamatelopoulos KS, et al. Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women. Am Heart J. 2004;147:1093–9.PubMedCrossRef Stamatelopoulos KS, et al. Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women. Am Heart J. 2004;147:1093–9.PubMedCrossRef
26.
go back to reference Nuver J, et al. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol. 2005;23:9130–7.PubMedCrossRef Nuver J, et al. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol. 2005;23:9130–7.PubMedCrossRef
27.
go back to reference Tzonevska A, Tzvetkov K, Parvanova V, Dimitrova M. 99mTc-MIBI myocardial perfusion scitigraphy for assessment of myocardial damage after radiotherapy in patients with breast cancer. J BUON. 2006;11:505–9.PubMed Tzonevska A, Tzvetkov K, Parvanova V, Dimitrova M. 99mTc-MIBI myocardial perfusion scitigraphy for assessment of myocardial damage after radiotherapy in patients with breast cancer. J BUON. 2006;11:505–9.PubMed
28.
go back to reference Hardenbergh PH, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys. 2001;49:1023–8.PubMedCrossRef Hardenbergh PH, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys. 2001;49:1023–8.PubMedCrossRef
29.
go back to reference Correa CR, et al. Association between tangential beam treatment and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2008;72:508–16.PubMedCrossRef Correa CR, et al. Association between tangential beam treatment and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2008;72:508–16.PubMedCrossRef
30.
go back to reference Chandra S, Lenihan DJ, Wei W, Yusuf SW, Tong AT. Myocardial perfusion imaging and cardiovascular outcomes in a cancer population. Tex Heart Inst J. 2009;36:205–13.PubMed Chandra S, Lenihan DJ, Wei W, Yusuf SW, Tong AT. Myocardial perfusion imaging and cardiovascular outcomes in a cancer population. Tex Heart Inst J. 2009;36:205–13.PubMed
31.
go back to reference Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.PubMedCrossRef Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.PubMedCrossRef
32.
go back to reference Espinola-Klein C, et al. Impact of intectious burden on progression of carotid atherosclerosis. Stroke. 2002;33:2581–6.PubMedCrossRef Espinola-Klein C, et al. Impact of intectious burden on progression of carotid atherosclerosis. Stroke. 2002;33:2581–6.PubMedCrossRef
33.
go back to reference Debier C, Larondelle Y. Vitamins A and E: metabolism, roles and transfer to offspring. Br J Nutr. 2005;93:153–74.PubMedCrossRef Debier C, Larondelle Y. Vitamins A and E: metabolism, roles and transfer to offspring. Br J Nutr. 2005;93:153–74.PubMedCrossRef
34.
go back to reference Banks RE, et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol. 1995;102:217–23.PubMedCrossRef Banks RE, et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol. 1995;102:217–23.PubMedCrossRef
35.
go back to reference McMillan DC, et al. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr. 2002;21:161–4.PubMedCrossRef McMillan DC, et al. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr. 2002;21:161–4.PubMedCrossRef
36.
go back to reference Mayland C, Allen KR, Degg TJ, Bennet M. Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response. Ann Clin Biochem. 2004;41:138–41.PubMedCrossRef Mayland C, Allen KR, Degg TJ, Bennet M. Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response. Ann Clin Biochem. 2004;41:138–41.PubMedCrossRef
37.
go back to reference Kralickova P, Melichar B, Malir F, Roubal T. Renal tubular dysfunction and urinary zinc excretion in breast cancer patients treated with anthracycline-based combination chemotherapy. J Exp Clin Cancer Res. 2004;23:579–84.PubMed Kralickova P, Melichar B, Malir F, Roubal T. Renal tubular dysfunction and urinary zinc excretion in breast cancer patients treated with anthracycline-based combination chemotherapy. J Exp Clin Cancer Res. 2004;23:579–84.PubMed
Metadata
Title
Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy
Authors
Hana Kalábová
Bohuslav Melichar
Leoš Ungermann
Jiří Doležal
Lenka Krčmová
Markéta Kašparová
Jiří Plíšek
Radomír Hyšpler
Miroslav Pecka
Dagmar Solichová
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9593-1

Other articles of this Issue 4/2011

Medical Oncology 4/2011 Go to the issue